1. Can antibodies be “vegan”? A guide through the maze of today’s antibody generation methods
   Stefan Dübel, 2024, mAbs CrossRef
2. A Comprehensive ddPCR Strategy for Sensitive and Reliable Monitoring of CAR-T Cell Kinetics in Clinical Applications
   Gertrud Wiedemann et al, 2024, International Journal of Molecular Sciences CrossRef
3. The state-of-the-art of N-of-1 therapies and the IRDiRC N-of-1 development roadmap
   Anneliene H. Jonker et al, 2024, Nature Reviews Drug Discovery CrossRef
4. Cellular immunotherapies and immune cell depleting therapies in inflammatory bowel diseases: the next magic bullet?
   Markus Friedrich Neurath et al, 2025, Gut CrossRef
5. Synthetic Gene Circuits as a Promising Approach in Cancer Immunotherapy
   Bhanuprakash Ananthakumar et al, 2024, Critical Developments in Cancer Immunotherapy CrossRef
6. Specific antitumor activity of anti-CA125 CAR-T lymphocytes against CA125-positive and CA125-negative cells
   T. M. Kulinich et al, 2024, Sechenov Medical Journal CrossRef
7. Immunological aspects of HTLV-1 persistence; for the prevention and treatment of Adult T-cell leukaemia-lymphoma (ATL)
   Devon A. Weterings et al, 2025, Leukemia Research CrossRef